总胆固醇水平下降预测慢性心力衰竭的死亡率更高
Mariana Matos1, Ana Neves1, Sérgio Madureira1
1Service of Internal Medicine, São João University Hospital, Porto, Portugal.
Minerva cardiology and angiology
|March 28, 2025
概括
在心力衰竭患者中,总胆固醇 (TC) 水平显著下降与死亡风险增加有关. 这一发现质疑他类药物在心力衰竭管理中的使用.
科学领域:
- 心脏病学 心脏病学
- 临床研究 临床研究
- 生物标志物 生物标志物
背景情况:
- 较低的总胆固醇 (TC) 与心力衰竭 (HF) 的不良结果有关.
- 在HF患者中TC变化的预后意义仍然不清楚.
- 了解TC动态对于高频管理至关重要.
研究的目的:
- 调查TC变异对慢性心力衰竭患者死亡率的影响.
- 要确定TC水平的下降是否预测HF的不良结果.
- 评估TC变化与全因死亡率之间的关联.
主要方法:
- 慢性HF和缩功能障碍的成年门诊患者 (2012-2020年) 的回顾性分析.
- 从基线到1年随访的百分比变化计算的TC变化.
- 考克斯回归分析用于评估与TC降低≥10%相关的死亡风险.
主要成果:
- 总共有362名患者被分析;35.1%的患者在第一年内经历了TC≥10%的下降.
- 患有≥10%的TC降低的患者的死亡率更高 (41.7%与32.8%相比).
- 多变量分析显示,在TC降低≥10%的患者中,所有原因死亡风险独立增加71% (HR1.71).
结论:
- 在TC下降≥10%独立预测心力衰竭患者的死亡风险显著更高.
- 这些发现支持HF中的"胆固醇悖论".
- 这些结果引发了对这种人群中他类药物治疗的疗效和安全性的疑问.
相关概念视频
Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

